skip to Main Content

Process Development Improvements Post-Pandemic

Dr. Blackwell, Founder and Principal Consultant at The Windshire Group, comments on learnings for process development as a result of meeting pandemic challenges. There are considerations for routine development for conventional therapeutics and for future pandemic responses.

BioPharm International:

Pharmaceutical Technology:

Process Development Forum (joint project with Cytiva):

Back To Top